New hiPSC tools for astroglial-focused approaches to ALS
$789,962U24FY2013NSNIH
Johns Hopkins University, Baltimore MD
Investigators
Linked publications & trials
Paper 36103513Paper 35115730Paper 29628143Paper 26308891Paper 26295203Paper 25760436Paper 24704492Paper 24703839
Abstract
At the time of submission of the orginal ALS iPS Go Grant, there were no well-validated protocols for generating astroglia from human ES or IPS cell lines, although approaches from rodent cells existed. Fortunately, we were able to develop a reliable protocol in both the Henderson lab and the Rothstein labs (Figure 5A). We now have a protocol that works identically in both labs¿with very similar efficiency at differentiation between labs. We have also been able to detect evidence of true astroglial maturation in a number of lines that have advanced sufficiently and these express appropriate astroglial specific proteins and have functional glutamate transport (Figure 5B-D).
View original record on NIH RePORTER →